Revealing Engagement Patterns Among Endometrial Cancer Patients

Part of paid clinical trials in San Francisco, California.

Sponsor
Power Life Sciences Inc.
Study ID
NCT05998798
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The study intends to investigate the personal experiences of endometrial cancer patients who take part in a separate clinical study including a specific medication intervention. The major focus will be on closely following individuals' rates of trial completion and withdrawal. The data collected from this study will help improve future outcomes for all endometrial cancer patients as well as those in under-represented demographic groups.

Key Dates

Start date
Sep 30, 2024
Status verified
Aug 2023
Primary completion
Sep 30, 2025
Completion
Sep 30, 2026

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Number of patients who decide to enroll in an endometrial cancer clinical research [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Power Life SciencesSan FranciscoCalifornia94107
Michael B Gill
https://www.withpower.com/[email protected]
415-900-4227

Find similar trials in San Francisco, CA

By condition
Endometrial cancer
By specialty
OncologyGynecologic oncologyWomen's health
By research site
Power Life Sciences· San Francisco, CA

Related Studies